$VXRT
Vaxart, Inc. Stock $vxrt

$vxrt Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-K Financial Statement

#000143774915017193 Filed on September 11, 2015

Income Statement

Concept	2015 Q2	2015	2014 Q2
Revenue	$4.100M	$24.60M	$8.500M
YoY Change	-51.76%	-64.19%	-8.6%
Cost Of Revenue	$24.10M	$3.600M	$19.00M
YoY Change	26.84%	-92.95%	171.43%
Gross Profit	-$20.00M	$21.00M	-$10.50M
YoY Change	90.48%	19.32%	-556.52%
Gross Profit Margin	-487.8%	85.37%	-123.53%
Selling, General & Admin	$1.200M	$9.400M	$2.200M
YoY Change	-45.45%	-7.84%	-48.84%
% of Gross Profit		44.76%
Research & Development	$24.20M	$19.80M	$6.200M
YoY Change	290.32%	13.14%	-1.59%
% of Gross Profit		94.29%
Depreciation & Amortization	$0.00	$1.100M	$1.000M
YoY Change	-100.0%	-54.17%	66.67%
% of Gross Profit		5.24%
Operating Expenses	$24.10M	$19.80M	$8.400M
YoY Change	186.9%	13.14%	-20.0%
Operating Profit	-$44.10M	-$19.50M	-$18.90M
YoY Change	133.33%	69.57%	130.49%
Interest Expense	$0.00	$6.800M	-$700.0K
YoY Change	-100.0%	-666.67%	-135.0%
% of Operating Profit
Other Income/Expense, Net	$0.00	$300.0K	$0.00
YoY Change		50.0%	-100.0%
Pretax Income	-$20.00M	-$19.20M	-$10.40M
YoY Change	92.31%	69.91%	65.08%
Income Tax	-$100.0K	-$100.0K	-$200.0K
% Of Pretax Income
Net Earnings	-$19.90M	-$19.10M	-$10.20M
YoY Change	95.1%	73.64%	56.92%
Net Earnings / Revenue	-485.37%	-77.64%	-120.0%
Basic Earnings Per Share	-$0.55	-$0.54	-$0.29
Diluted Earnings Per Share	-$0.55	-$0.54	-$0.29
COMMON SHARES
Basic Shares Outstanding		35.36M
Diluted Shares Outstanding		35.36M

Balance Sheet

Concept	2015 Q2	2015	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$57.60M	$57.60M	$81.70M
YoY Change	-29.5%	-29.5%	22.31%
Cash & Equivalents	$44.70M	$44.70M	$81.70M
Short-Term Investments	$12.90M	$12.90M
Other Short-Term Assets	$600.0K	$600.0K	$700.0K
YoY Change	-14.29%	-14.29%	-68.18%
Inventory
Prepaid Expenses
Receivables	$12.60M	$12.60M	$18.70M
Other Receivables	$12.60M	$0.00	$900.0K
Total Short-Term Assets	$70.80M	$70.80M	$101.1M
YoY Change	-29.97%	-29.97%	26.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$200.0K	$200.0K	$2.000M
YoY Change	-90.0%	-90.0%	-53.49%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$7.900M	$7.900M	$10.00M
YoY Change	-21.0%	-21.0%
Other Assets	$500.0K	$500.0K	$900.0K
YoY Change	-44.44%	-44.44%	-40.0%
Total Long-Term Assets	$8.600M	$8.600M	$12.90M
YoY Change	-33.33%	-33.33%	122.41%
TOTAL ASSETS
Total Short-Term Assets	$70.80M	$70.80M	$101.1M
Total Long-Term Assets	$8.600M	$8.600M	$12.90M
Total Assets	$79.40M	$79.40M	$114.0M
YoY Change	-30.35%	-30.35%	32.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.900M	$1.900M	$2.800M
YoY Change	-32.14%	-32.14%	16.67%
Accrued Expenses	$5.400M	$3.700M	$3.400M
YoY Change	58.82%	-2.63%	-50.72%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$200.0K	$200.0K
YoY Change		0.0%
Total Short-Term Liabilities	$9.000M	$9.000M	$26.90M
YoY Change	-66.54%	-66.54%	52.84%
LONG-TERM LIABILITIES
Long-Term Debt	$800.0K	$800.0K	$0.00
YoY Change
Other Long-Term Liabilities	$100.0K	$100.0K	$200.0K
YoY Change	-50.0%	-50.0%	0.0%
Total Long-Term Liabilities	$100.0K	$900.0K	$200.0K
YoY Change	-50.0%	350.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.000M	$9.000M	$26.90M
Total Long-Term Liabilities	$100.0K	$900.0K	$200.0K
Total Liabilities	$9.900M	$9.900M	$27.10M
YoY Change	-63.47%	-63.47%	52.25%
SHAREHOLDERS EQUITY
Retained Earnings	-$108.9M		-$89.80M
YoY Change	21.27%
Common Stock	$159.5M		$149.9M
YoY Change	6.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$69.50M	$69.50M	$86.90M
YoY Change
Total Liabilities & Shareholders Equity	$79.40M	$79.40M	$114.0M
YoY Change	-30.35%	-30.35%	32.87%

Cashflow Statement

Concept	2015 Q2	2015	2014 Q2
OPERATING ACTIVITIES
Net Income	-$19.90M	-$19.10M	-$10.20M
YoY Change	95.1%	73.64%	56.92%
Depreciation, Depletion And Amortization	$0.00	$1.100M	$1.000M
YoY Change	-100.0%	-54.17%	66.67%
Cash From Operating Activities	$200.0K	-$9.600M	$10.60M
YoY Change	-98.11%	190.91%	324.0%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$100.0K	$100.0K
YoY Change	-100.0%	0.0%	-120.0%
Acquisitions		$8.900M
YoY Change
Other Investing Activities	-$16.70M	-$19.30M	-$10.00M
YoY Change	67.0%	93.0%
Cash From Investing Activities	-$16.70M	-$19.40M	-$9.900M
YoY Change	68.69%	92.08%	1880.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-100.0K	-100.0K	0.000
YoY Change		-100.37%
NET CHANGE
Cash From Operating Activities	200.0K	-9.600M	10.60M
Cash From Investing Activities	-16.70M	-19.40M	-9.900M
Cash From Financing Activities	-100.0K	-100.0K	0.000
Net Change In Cash	-16.60M	-29.10M	700.0K
YoY Change	-2471.43%	-317.16%	-65.0%
FREE CASH FLOW
Cash From Operating Activities	$200.0K	-$9.600M	$10.60M
Capital Expenditures	$0.00	$100.0K	$100.0K
Free Cash Flow	$200.0K	-$9.700M	$10.50M
YoY Change	-98.1%	185.29%	250.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0000072444
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Registrant Name EntityRegistrantName	Biota Pharmaceuticals, Inc.
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015Q2	bota	Net Financial Assets NetFinancialAssets	61700000
CY2014Q2	bota	Net Financial Assets NetFinancialAssets	74400000
CY2015Q2	bota	Accrued Research And Development Materials And Services AccruedResearchAndDevelopmentMaterialsAndServices	1700000
CY2014Q2	bota	Accrued Research And Development Materials And Services AccruedResearchAndDevelopmentMaterialsAndServices	800000
CY2015	bota	Available For Sale Securities Maturity Period AvailableForSaleSecuritiesMaturityPeriod	P2Y
CY2015Q2	bota	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net Before Iprd BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetBeforeIPRD	-1100000
CY2015Q2	bota	Current Financial Assets CurrentFinancialAssets	70200000
CY2014Q2	bota	Current Financial Assets CurrentFinancialAssets	100400000
CY2015Q2	bota	Current Financial Liabilities CurrentFinancialLiabilities	8500000
CY2014Q2	bota	Current Financial Liabilities CurrentFinancialLiabilities	26000000
CY2015Q2	bota	Deferred Tax Assets Accrued Compensated Related Costs DeferredTaxAssetsAccruedCompensatedRelatedCosts	1400000
CY2014Q2	bota	Deferred Tax Assets Accrued Compensated Related Costs DeferredTaxAssetsAccruedCompensatedRelatedCosts	800000
CY2015Q2	bota	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	600000
CY2014Q2	bota	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	800000
CY2015Q2	bota	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation
CY2014Q2	bota	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	600000
CY2015	bota	Gain Loss On Merger GainLossOnMerger
CY2014	bota	Gain Loss On Merger GainLossOnMerger
CY2013	bota	Gain Loss On Merger GainLossOnMerger	7600000
CY2015	bota	Impairment Of Financial Assets ImpairmentOfFinancialAssets	0
CY2014	bota	Impairment Of Financial Assets ImpairmentOfFinancialAssets	0
CY2015	bota	Income Tax Rate Reconciliation Legal Ip Expense Amount IncomeTaxRateReconciliationLegalIPExpenseAmount	6900000
CY2014	bota	Income Tax Rate Reconciliation Legal Ip Expense Amount IncomeTaxRateReconciliationLegalIPExpenseAmount
CY2013	bota	Income Tax Rate Reconciliation Legal Ip Expense Amount IncomeTaxRateReconciliationLegalIPExpenseAmount
CY2015	bota	Increase Decrease Accrued Severance Obligations IncreaseDecreaseAccruedSeveranceObligations	-2000000
CY2014	bota	Increase Decrease Accrued Severance Obligations IncreaseDecreaseAccruedSeveranceObligations	-1000000
CY2013	bota	Increase Decrease Accrued Severance Obligations IncreaseDecreaseAccruedSeveranceObligations	-2400000
CY2015	bota	Loss Gain Recorded On Merger LossGainRecordedOnMerger
CY2014	bota	Loss Gain Recorded On Merger LossGainRecordedOnMerger
CY2013	bota	Loss Gain Recorded On Merger LossGainRecordedOnMerger	7600000
CY2015Q2	bota	Number Of Operating Leases NumberOfOperatingLeases	1
CY2015Q2	bota	Operating Leases Future Minimum Payments Due After Year Three OperatingLeasesFutureMinimumPaymentsDueAfterYearThree	0
CY2015	bota	Proceeds To Settle Accrued Severance Obligations And Other Accrued Liabilities On Merger ProceedsToSettleAccruedSeveranceObligationsAndOtherAccruedLiabilitiesOnMerger
CY2014	bota	Proceeds To Settle Accrued Severance Obligations And Other Accrued Liabilities On Merger ProceedsToSettleAccruedSeveranceObligationsAndOtherAccruedLiabilitiesOnMerger
CY2013	bota	Proceeds To Settle Accrued Severance Obligations And Other Accrued Liabilities On Merger ProceedsToSettleAccruedSeveranceObligationsAndOtherAccruedLiabilitiesOnMerger	5700000
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38609086
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2014	bota	Research And Development Credit ResearchAndDevelopmentCredit	0
CY2015	bota	Research And Development Credit ResearchAndDevelopmentCredit	0
CY2013	bota	Research And Development Credit ResearchAndDevelopmentCredit	4400000
CY2015Q2	bota	Severance Obligations Accrued SeveranceObligationsAccrued	100000
CY2014Q2	bota	Severance Obligations Accrued SeveranceObligationsAccrued	1200000
CY2014Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2014Q4	dei	Entity Public Float EntityPublicFloat	78100000
CY2015Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	8300000
CY2014Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	26000000
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1900000
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2800000
CY2015Q2	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms
CY2014Q2	us-gaap	Accounts Receivable Billed For Long Term Contracts Or Programs AccountsReceivableBilledForLongTermContractsOrPrograms	17800000
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12600000
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18700000
CY2015Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5300000
CY2014Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3400000
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5300000
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3400000
CY2015Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	800000
CY2014Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1000000
CY2015Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	500000
CY2014Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1100000
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	200000
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25700000
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	18900000
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	26800000
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	155600000
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	146400000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2600000
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1400000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2100000
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3604737
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2725441
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1828668
CY2015Q2	us-gaap	Assets Assets	79400000
CY2014Q2	us-gaap	Assets Assets	114000000
CY2015Q2	us-gaap	Assets Current AssetsCurrent	70800000
CY2014Q2	us-gaap	Assets Current AssetsCurrent	101100000
CY2015Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	8600000
CY2014Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	12900000
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	27100000
CY2014Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	46900000
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2014Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2015Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	100000
CY2015Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	27100000
CY2014Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	46900000
CY2015Q2	us-gaap	Available For Sale Securities Short Term Investments Amortized Cost AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCost	27200000
CY2014Q2	us-gaap	Available For Sale Securities Short Term Investments Amortized Cost AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCost	46900000
CY2013	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	32700000
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44700000
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81700000
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66800000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53800000
CY2013	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	19200000
CY2015	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition
CY2014	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-29100000
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	13400000
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	17800000
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38609086
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35100961
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38609086
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35100961
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	3900000
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	3500000
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13100000
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9500000
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27000000
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Concentration of Credit Risk and Other Risks and Uncertainties</div></div></div></div><div style=" MARGIN-BOTTOM: 0pt; MARGIN-TOP: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Cash, cash equivalents and short- and long-term investments consist of financial instruments that potentially subject the Company to concentrations of credit risk to the extent recorded on the balance sheets. The Company believes that it has established guidelines for investment of its excess cash that maintain principal and liquidity through its policies on concentration, diversification, investment maturity, and investment grade.</div></div></div></div></div></div></div>
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	24100000
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	4800000
CY2014Q4	us-gaap	Cost Of Revenue CostOfRevenue	7500000
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	7700000
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	19000000
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	26300000
CY2013Q4	us-gaap	Cost Of Revenue CostOfRevenue	18600000
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	16300000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8800000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	7500000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3000000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-15300000
CY2015	us-gaap	Cost Of Services CostOfServices	3600000
CY2014	us-gaap	Cost Of Services CostOfServices	51100000
CY2013	us-gaap	Cost Of Services CostOfServices	19700000
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-100000
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-300000
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	100000
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-100000
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-300000
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	100000
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2015Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	27600000
CY2014Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	27500000
CY2015Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2014Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet
CY2015Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	500000
CY2014Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	900000
CY2015Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	500000
CY2014Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1100000
CY2015Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	500000
CY2014Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	900000
CY2015Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	5400000
CY2014Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	2800000
CY2015Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	19800000
CY2014Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	18200000
CY2015Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	400000
CY2014Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	4300000
CY2015Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27100000
CY2014Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26400000
CY2015Q2	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	500000
CY2014Q2	us-gaap	Deferred Tax Liabilities Current DeferredTaxLiabilitiesCurrent	900000
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	400000
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	800000
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1100000
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1100000
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2400000
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3000000
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.54
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2015	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.54
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.55
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.54
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-7900000
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1500000
CY2013	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-4800000
CY2015Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1600000
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	400000
CY2014	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
CY2015	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3200000
CY2015	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	0
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-100000
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300000
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-26700000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19200000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11300000
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4100000
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4200000
CY2015	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	-400000
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	800000
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6500000
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1400000
CY2013	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1900000
CY2015	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-200000
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1
CY2013	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1
CY2015	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9400000
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10200000
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18000000
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2800000
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6200000
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-8300000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	6500000
CY2014	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	-100000
CY2013	us-gaap	Income Tax Reconciliation Deductions Other IncomeTaxReconciliationDeductionsOther	3000000
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-400000
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	400000
CY2013	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1300000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6700000
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4000000
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3300000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	-100000
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	1100000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	500000
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	200000
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-200000
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	100000
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1000000
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-300000
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	300000
CY2015	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	200000
CY2014	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign
CY2013	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign
CY2015	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	100000
CY2014	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	300000
CY2013	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1100000
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-15800000
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	10600000
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7100000
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4200000
CY2015	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes
CY2014	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes
CY2013	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1500000
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-300000
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-100000
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-100000
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1400000
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	600000
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1100000
CY2015Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	200000
CY2014Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	6900000
CY2015Q2	us-gaap	Liabilities Liabilities	9900000
CY2014Q2	us-gaap	Liabilities Liabilities	27100000
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79400000
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	114000000
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	9000000
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	26900000
CY2015Q2	us-gaap	Long Term Investments LongTermInvestments	7900000
CY2014Q2	us-gaap	Long Term Investments LongTermInvestments	10000000
CY2015Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	800000
CY2014Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-100000
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	26800000
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19400000
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10100000
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	31700000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9600000
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3300000
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13900000
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-8900000
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-11000000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-19100000
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-19900000
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	1200000
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	6500000
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-6900000
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-10200000
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	3200000
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-100000
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-3900000
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	7500000
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
CY2013	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	300000
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	200000
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13300000
CY2014Q2	us-gaap	Notes Payable Current NotesPayableCurrent
CY2015Q2	us-gaap	Notes Payable Current NotesPayableCurrent	200000
CY2015	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	44100000
CY2014	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	80200000
CY2013	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	55700000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-19500000
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-11500000
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-22100000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	500000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	100000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	200000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	200000
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1200000
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1200000
CY2013	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4200000
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1500000
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7800000
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	100000
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	200000
CY2015	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	300000
CY2014	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	200000
CY2013	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1300000
CY2015	us-gaap	Other Operating Income OtherOperatingIncome	100000
CY2014	us-gaap	Other Operating Income OtherOperatingIncome	100000
CY2013	us-gaap	Other Operating Income OtherOperatingIncome	800000
CY2015Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	12600000
CY2014Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	900000
CY2015	us-gaap	Payments For Restructuring PaymentsForRestructuring	2000000
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8900000
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired
CY2015	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	17700000
CY2014	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	10000000
CY2013	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100000
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100000
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1000000
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	600000
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	700000
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	26800000
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2015	us-gaap	Proceeds From Maturities Prepayments And Calls Of Longterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments	6900000
CY2014	us-gaap	Proceeds From Maturities Prepayments And Calls Of Longterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments
CY2013	us-gaap	Proceeds From Maturities Prepayments And Calls Of Longterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfLongtermInvestments
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	400000
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	400000
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27700000
CY2015Q2	us-gaap	Property Plant And Equipment Gross Excluding Capital Leased Assets PropertyPlantAndEquipmentGrossExcludingCapitalLeasedAssets	200000
CY2014Q2	us-gaap	Property Plant And Equipment Gross Excluding Capital Leased Assets PropertyPlantAndEquipmentGrossExcludingCapitalLeasedAssets	20800000
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	200000
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2000000
CY2014Q2	us-gaap	Restructuring Reserve RestructuringReserve	2000000
CY2015Q2	us-gaap	Restructuring Reserve RestructuringReserve
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-108900000
CY2015	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	100000
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19800000
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17500000
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19900000
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89800000
CY2015	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	17600000
CY2014	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess
CY2013	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess
CY2015	us-gaap	Revenues Revenues	24600000
CY2014	us-gaap	Revenues Revenues	68700000
CY2013	us-gaap	Revenues Revenues	33600000
CY2015Q2	us-gaap	Revenues Revenues	4100000
CY2015Q1	us-gaap	Revenues Revenues	5900000
CY2014Q4	us-gaap	Revenues Revenues	13900000
CY2014Q3	us-gaap	Revenues Revenues	700000
CY2014Q2	us-gaap	Revenues Revenues	8500000
CY2014Q1	us-gaap	Revenues Revenues	29500000
CY2013Q4	us-gaap	Revenues Revenues	18500000
CY2013Q3	us-gaap	Revenues Revenues	12200000
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	16100000
CY2014	us-gaap	Royalty Revenue RoyaltyRevenue	15100000
CY2013	us-gaap	Royalty Revenue RoyaltyRevenue	9600000
CY2015	us-gaap	Sales Revenue Services Gross SalesRevenueServicesGross	8400000
CY2014	us-gaap	Sales Revenue Services Gross SalesRevenueServicesGross	53600000
CY2013	us-gaap	Sales Revenue Services Gross SalesRevenueServicesGross	24000000
CY2015	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	8400000
CY2014	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	53500000
CY2013	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	23200000
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.42
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31347888
CY2015	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y332D
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28217515
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.09
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.58
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	2100000
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	1700000
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2600000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.017
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.015
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.015
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.0082
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.0079
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.0079
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	531252
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.37
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1432000
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.65
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.47
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.39
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2463369
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3364117
CY2015	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
CY2015Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1229088
CY2015Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	3364117
CY2015	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y328D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y328D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y328D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
CY2015Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	10.16
CY2015Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	5.58
CY2015Q2	us-gaap	Short Term Investments ShortTermInvestments	12900000
CY2014Q2	us-gaap	Short Term Investments ShortTermInvestments
CY2015	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26800000
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7500000
CY2014	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	200000
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	59300000
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	68000000
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	86900000
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	69500000
CY2013	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount
CY2015Q2	us-gaap	Treasury Stock Value TreasuryStockValue
CY2014Q2	us-gaap	Treasury Stock Value TreasuryStockValue
CY2015	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-100000
CY2014	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments
CY2013	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments
CY2015Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> </div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of the consolidated financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include accruals and obligations, tangible and intangible assets and deferred income taxes. Actual results could differ from those estimates.</div></div></div></div></div></div></div>
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35367117
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31347888
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28217515
CY2015	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35360841
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	31347888
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28217515
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35367117

Files In Submission

Name	View Source	Status
0001437749-15-017193-index-headers.html	Edgar Link	pending
0001437749-15-017193-index.html	Edgar Link	pending
0001437749-15-017193.txt	Edgar Link	pending
0001437749-15-017193-xbrl.zip	Edgar Link	pending
a1.jpg	Edgar Link	pending
a2.jpg	Edgar Link	pending
a3.jpg	Edgar Link	pending
bota-20150630.xml	Edgar Link	completed
bota-20150630.xsd	Edgar Link	pending
bota-20150630_cal.xml	Edgar Link	unprocessable
bota-20150630_def.xml	Edgar Link	unprocessable
bota-20150630_lab.xml	Edgar Link	unprocessable
bota-20150630_pre.xml	Edgar Link	unprocessable
bota20150630_10k.htm	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex23-1a.htm	Edgar Link	pending
ex23-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VXRT
Vaxart, Inc. Stock $vxrt

2015 Q2 Form 10-K Financial Statement

#000143774915017193 Filed on September 11, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VXRT Vaxart, Inc. Stock $vxrt

2015 Q2 Form 10-K Financial Statement

#000143774915017193 Filed on September 11, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VXRT
Vaxart, Inc. Stock $vxrt